08:59:11 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



BCSC rules against Hamilton, clears Lichti

2018-10-10 19:10 ET - Street Wire

Also Street Wire (U-GSTV) Global Stevia Corp

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Mike Caswell

The B.C. Securities Commission has found against Vancouver resident Matthew John Hamilton, determining his behaviour in connection with the sale of a U.S. shell company was "clearly abusive." Among other things, he hid his control over all of the company's shares while installing a nominee officer and director. He also provided false records in order to obtain a U.S. symbol for the company.

The ruling comes as part of an administrative case in which the BCSC cited Mr. Hamilton and another man, Braeden Lichti. The regulator claimed that the pair were behind the creation and sale of Guru Health Inc., an OTC Bulletin Board shell. On paper the company had 27 shareholders and a Calgary woman as its chief executive officer, but in reality Mr. Hamilton had complete control of the company's shares, the BCSC said. In 2012, he and Mr. Lichti sold the company as a shell for $220,000 (U.S.), according to the BCSC.

The matter went before a three-member panel, which heard the allegations over seven days in February and March, 2018. Mr. Hamilton and Mr. Lichti both opposed the matter, each sending a lawyer to the hearing. Among other things, they contended that the rules the BCSC used to pursue them had no relation to what they did. There is no provision in the province's securities regulation for "deceptive shell manufacturing," they said.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed